Results 41 to 50 of about 153,933 (198)
Structural proteomics of dengue virus [PDF]
Current Opinion in Microbiology, 2008 In this paper, we discuss recent advances in our knowledge of the dengue virus life cycle based on new structural data of the virus and its proteins. Specifically, we focus on the structure of the pre-membrane protein, prM and its role in virus assembly, the first full-length structure of a multi-domain dengue virus replication protein, NS3, and the ...
Rushika Perera, Richard J. Kuhn
openaire +2 more sources
Neutropenia as an adverse event following vaccination : results from randomized clinical trials in healthy adults and systematic review [PDF]
, 2016 Background : In the context of early vaccine trials aimed at evaluating the safety profile of novel vaccines, abnormal haematological values, such as neutropenia, are often reported.
Aerssens, Annelies +10 more
core +4 more sources
Dengue Virus Seroconversion in Travelers to Dengue-Endemic Areas [PDF]
The American Society of Tropical Medicine and Hygiene, 2016 We conducted a prospective study to measure dengue virus (DENV) antibody seroconversion in travelers to dengue-endemic areas. Travelers seen in the Boston Area Travel Medicine Network planning to visit dengue-endemic countries for ≥ 2 weeks were enrolled from 2009 to 2010. Pre- and post-travel blood samples and questionnaires were collected.
Nina Marano +15 more
openaire +3 more sources
On the Dynamics of Dengue Virus type 2 with Residence Times and Vertical Transmission
, 2016 A two-patch mathematical model of Dengue virus type 2 (DENV-2) that accounts for vectors' vertical transmission and between patches human dispersal is introduced. Dispersal is modeled via a Lagrangian approach.
Bichara, Derdei +4 more
core +2 more sources
Historical Patterns of Arboviral Seroprevalence across Africa and Asia [PDF]
, 2017 The emergence and resurgence of arboviruses in recent history is challenging our scientific understanding of mosquito-borne diseases and their transmission.
Chrisafis, George C
core +1 more source
Dengue virus infections and anti-dengue virus activities of Andrographis paniculata
Asian Pacific Journal of Tropical Medicine, 2020 Dengue is a debilitating disease that poses a perpetual threat to human health and increases the global economic burden every year. Despite advances in medical sciences, dengue virus (DENV) infects approximately 200 million people every year. To date, no effective antiviral is valiable to treat DENV in individuals despite great efforts in accomplishing
Mohamed Ali-Seyed +1 more
openaire +3 more sources
Immature Dengue Virus: A Veiled Pathogen?
PLoS Pathogens, 2010 Cells infected with dengue virus release a high proportion of immature prM-containing virions. In accordance, substantial levels of prM antibodies are found in sera of infected humans. Furthermore, it has been recently described that the rates of prM antibody responses are significantly higher in patients with secondary infection compared to those with
Rodenhuis-Zybert, I.A. +6 more
openaire +8 more sources
Peptide Bbeta(15-42) preserves endothelial barrier function in shock [PDF]
, 2009 Loss of vascular barrier function causes leak of fluid and proteins into tissues, extensive leak leads to shock and death. Barriers are largely formed by endothelial cell-cell contacts built up by VE-cadherin and are under the control of RhoGTPases. Here
Atrasheuskaya, Alena +12 more
core
ヤマガタ ダイガク イガクブ フゾク ビョウイン ニオケル デングネツ ノ ソウキ ハッケン [PDF]
, 2005 Dengue fever (DF) is an acute febrile disease caused by dengue virus, which was re-emerged in tropical regions in the past 20 years. The numbers of imported DF were 6 to 44 per year in the recent Japan.
Harada Hiroko +2 more
core +1 more source